Rong XinQian, Shen CanTing, Shu QingLong
Jiangxi University of Chinese Medicine, Nanchang, China.
Phytother Res. 2024 Sep;38(9):4695-4715. doi: 10.1002/ptr.8284. Epub 2024 Aug 9.
Polysaccharides are one of the most important components of traditional Chinese medicine (TCM) and have been extensively studied for their immunomodulatory properties. The functions and effects of TCM polysaccharides are closely related to the gut microbiota, making the study of their interaction a hot topic in the field of TCM metabolism. This review follows two main inquiries: first, how the gut microbiota breaks down TCM polysaccharides to produce bioactive metabolites; and second, how TCM polysaccharides reshape the gut microbiota as a carbon source. Understanding the interaction mechanism involves a challenging equation of the structural association of TCM polysaccharides with the metabolic activities of the microbiota. This review has meticulously searched, partially organized literature spanning the past decade, that delves into the interaction mechanism between TCM polysaccharides and gut microbiota. It also gives an overview of the complex factors of the elusive "polysaccharides-bond-bacteria-enzyme" equation: the complexity of polysaccharide structures, the diversity of glycosidic bond types, the communal nature of metabolizing microbiota, the enzymes involved in functional degradation by microbiota, and the hierarchical roles of polysaccharide utilization locus and gram-positive PULs. Finally, this review aims to facilitate discussion among peers in the field of TCM microbiota and offers prospects for research in related fields, paving the way for pharmacological studies on TCM polysaccharides and gut microbiota therapeutics, and providing a reference point for further clinical research.
多糖是中药最重要的成分之一,其免疫调节特性已得到广泛研究。中药多糖的功能和作用与肠道微生物群密切相关,这使得对它们相互作用的研究成为中药代谢领域的一个热门话题。本综述主要探讨两个问题:第一,肠道微生物群如何分解中药多糖以产生生物活性代谢物;第二,中药多糖如何作为碳源重塑肠道微生物群。理解相互作用机制涉及到一个具有挑战性的等式,即中药多糖的结构与微生物群代谢活动之间的关联。本综述精心检索、部分整理了过去十年的文献,这些文献深入探讨了中药多糖与肠道微生物群之间的相互作用机制。它还概述了难以捉摸的“多糖-键-细菌-酶”等式的复杂因素:多糖结构的复杂性、糖苷键类型的多样性、代谢微生物群的共同性质、微生物群参与功能降解的酶,以及多糖利用位点和革兰氏阳性菌多糖利用位点的层级作用。最后,本综述旨在促进中药微生物群领域同行之间的讨论,并为相关领域的研究提供前景,为中药多糖和肠道微生物群治疗的药理学研究铺平道路,并为进一步的临床研究提供参考点。